The Goldman Sachs technology M&A team, led by Sam Britton, has cashed in on its software focus and decades of experience to dominate 2019's biggest deals.Technologyread more
American small and medium-size companies that rely on China are scrambling to adjust their business plans in response to the escalating trade war.Traderead more
Here are the products that stand to be the most affected by China's new tariffs on $75 billion worth of U.S. goods.Marketsread more
The summit comes amid fears over a global economic slowdown, and U.S. tensions over trade allies, Iran and Russia.Politicsread more
The world's second biggest economy is past a point where it cannot ignore its enormous debt anymore, according to an analyst.China Economyread more
Carl Medlock used to work at Tesla. Now he's one of the few people in the U.S. that can fix the company's original Roadster electric vehicles.Technologyread more
Trump does have some powerful tools that would not require approval from U.S. Congress.Politicsread more
Stocks dropped after Donald Trump ordered that U.S. manufacturers find alternatives to their operations in China.US Marketsread more
As demand for lab monkeys continues to rise, U.S. scientists are reporting delays in research projects because they can't obtain enough animals, according to the National...Politicsread more
The European Union will respond in kind if the U.S. imposes tariffs on France over digital tax plan, EU chief Donald Tusk told G-7.Technologyread more
Trump said he will raise tariffs on $250 billion in Chinese goods to 30% and hike duties on another $300 billion in products to 15%.Politicsread more
New York's Metropolitan Museum of Art announced Wednesday that it would no longer accept gifts from members of the Sackler family, the principal owners of a pharmaceutical company behind the painkiller blamed for fueling the deadly opioid epidemic.
The move comes after other leading cultural institutions, including the Guggenheim in New York and the Tate in London, said they would cut ties with the family amid recent legal scrutiny on Purdue Pharma's production of OxyContin.
"The Sackler family has graciously supported The Met for 50 years and has not proposed any new contributions," Met president and CEO Daniel Weiss said in a statement announcing the decision.
More from NBC News:
Prince Harry wins damages over aerial pictures of his and Meghan Markle's private home
Thousands honor teen who died trying to stop Colorado school shooting
Latina college senior's tribute to immigrant farm worker parents goes viral
"Nonetheless, in consideration of the ongoing litigation, the prudent course of action at this time is to suspend acceptance of gifts from individuals associated with this public health crisis," Weiss added.
The news was first reported by The New York Times.
The Met is one of several cultural centers that have enjoyed the Sacklers' largesse over decades, helping the family earn a reputation as transatlantic patrons of the arts and generous philanthropists. In addition to museums and galleries, members of the sprawling dynasty have also donated to top universities and medical facilities.
Purdue Pharma faces some 1,600 lawsuits that accuse it of promoting OxyContin while downplaying the drug's addictive properties. In March, it settled with the Oklahoma attorney general for $270 million, roughly two months before the scheduled start of a televised trial in the opioid-ravaged state.
Massachusetts last year named eight members of the Sackler family in a complaint that accused the company of spinning a "web of illegal deceit" to boost profits.
Purdue, which has denied the allegations, has generated sales of more than $35 billion since debuting OxyContin in 1995, according to Forbes.